<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="46f17ba7-a78c-4a9e-7597-27654f097bd3"><labelDrug name="ZESTRIL"><Normalization><mmtx cui="C0678140" preferredWord="Zestril" semType="phsu, aapp"/></Normalization></labelDrug><generic name="Lisinopril"/><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.1" text="ZESTRIL (lisinopril) tablet" type="negative"><entity charOffset="9:19" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.1.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="(lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.1.e.1" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.1.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.1.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.2" text="Lisinopril is an oral long-acting angiotensin converting enzyme inhibitor." type="negative"><entity charOffset="34:73" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.2.e.0" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="an oral long-acting angiotensin converting enzyme inhibitor." preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.2.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.2.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.2.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.4" text="ZESTRIL is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema." type="negative"><entity charOffset="161:200" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.4.e.0" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="with an angiotensin converting enzyme inhibitor" preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.4.e.1" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.4.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.4.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7" text="Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including ZESTRIL) may be subject to a variety of adverse reactions, some of them serious." type="negative"><entity charOffset="193:200" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7.e.0" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="19:59" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7.e.1" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7.e.2" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7.e.0"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.7.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.8" text="Head and Neck Angioedema: Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported in patients treated with angiotensin converting enzyme inhibitors, including ZESTRIL. " type="negative"><entity charOffset="142:182" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.8.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treated with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="194:201" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.8.e.1" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL." preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.8.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.8.e.1"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.12" text="Even in those instances where swelling of only the tongue is involved, without respiratory distress, patients may require prolonged observation since treatment with antihistamines and corticosteroids may not be sufficient. " type="negative"><entity charOffset="165:179" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.12.e.0" text="antihistamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0003360" phraseText="treatment with antihistamines" preferredWord="Antihistamines" semType="phsu, orch"/><RxNorm RxCui="967"/></Normalization></entity><entity charOffset="184:199" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.12.e.1" text="corticosteroids" type="Biomedical_Entity"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.12.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.12.e.1"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.19" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="142:155" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.19.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="129:137" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.19.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.19.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.19.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22" lineNumber="21" text="Anaphylactoid Reactions During Desensitization: Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="48:60" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.0" text="Two patients" type="SPAN"/><entity charOffset="101:118" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.1" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="135:149" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="177:200" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.3" text="anaphylactoid reactions" type="Specific_Interaction"/><entity charOffset="160:176" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.5" text="life-threatening" type="SPAN"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.3"><relations><relation type="hasEvidence"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.0"/></relation><relation type="hasSeverity"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.2" evidence="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.0" severity="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.5" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.22.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35" lineNumber="31" text="Patients at risk of excessive hypotension, sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mmHg, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. " type="irregular"><entity charOffset="304:312" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="high dose diuretic therapy," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="30:41" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="69:77" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.3" text="oliguria" type="Specific_Interaction"><Normalization><mmtx cui="C0028961" phraseText="associated with oliguria" preferredWord="Oliguria" semType="sosy"/></Normalization></entity><entity charOffset="97:105" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.5" text="azotemia" type="Specific_Interaction"><Normalization><mmtx cui="C0242528" phraseText="progressive azotemia," preferredWord="Azotemia" semType="dsyn"/><mmtx cui="C0554309" phraseText="progressive azotemia," preferredWord="Prerenal uremia syndrome" semType="dsyn"/></Normalization></entity><entity charOffset="123:142" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.7" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="rarely with acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="150:155" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.9" text="death" type="Specific_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32" text="Evidence from the two-dose ATLAS trial suggested that incidence of hypotension may increase with dose of lisinopril in heart failure patients. "><entity charOffset="105:115" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="increase with dose of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.33" text="Discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.34" text="caution should be observed when initiating therapy (See DOSAGE AND ADMINISTRATION)."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32" text="Evidence from the two-dose ATLAS trial suggested that incidence of hypotension may increase with dose of lisinopril in heart failure patients. "><entity charOffset="105:115" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="increase with dose of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.33" text="Discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.34" text="caution should be observed when initiating therapy (See DOSAGE AND ADMINISTRATION)."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.ddi.3"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32" text="Evidence from the two-dose ATLAS trial suggested that incidence of hypotension may increase with dose of lisinopril in heart failure patients. "><entity charOffset="105:115" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="increase with dose of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.33" text="Discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.34" text="caution should be observed when initiating therapy (See DOSAGE AND ADMINISTRATION)."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.ddi.4"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32" text="Evidence from the two-dose ATLAS trial suggested that incidence of hypotension may increase with dose of lisinopril in heart failure patients. "><entity charOffset="105:115" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="increase with dose of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.33" text="Discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.34" text="caution should be observed when initiating therapy (See DOSAGE AND ADMINISTRATION)."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.ddi.5"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32" text="Evidence from the two-dose ATLAS trial suggested that incidence of hypotension may increase with dose of lisinopril in heart failure patients. "><entity charOffset="105:115" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.32.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="increase with dose of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.33" text="Discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.34" text="caution should be observed when initiating therapy (See DOSAGE AND ADMINISTRATION)."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.35.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36" text="It may be advisable to eliminate the diuretic (except in patients with heart failure), reduce the diuretic dose or increase salt intake cautiously before initiating therapy with ZESTRIL in patients at risk for excessive hypotension who are able to tolerate such adjustments (See PRECAUTIONS, Drug Interactions and ADVERSE REACTIONS)." type="negative"><entity charOffset="98:106" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic dose" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="178:185" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36.e.1" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="increase salt intake cautiously before initiating therapy with ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="37:45" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36.e.2" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36.e.1"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.36.e.1"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.38" text="Treatment with ZESTRIL must not be initiated in acute myocardial infarction patients at risk of further serious hemodynamic deterioration after treatment with a vasodilator (e.g., systolic blood pressure of 100 mmHg or lower) or cardiogenic shock." type="negative"><entity charOffset="15:22" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.38.e.0" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="Treatment with ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="161:172" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.38.e.1" text="vasodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C3537240" phraseText="with a vasodilator" preferredWord="Vasodilator [EPC]" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.38.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.38.e.1"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.39" text="In patients at risk of excessive hypotension, therapy should be started under very close medical supervision and such patients should be followed closely for the first two weeks of treatment and whenever the dose of ZESTRIL and/or diuretic is increased. " type="negative"><entity charOffset="216:223" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.39.e.0" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="the dose of ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="231:239" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.39.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.39.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.39.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43" lineNumber="37" text="If symptomatic hypotension develops, a dose reduction or discontinuation of ZESTRIL or concomitant diuretic may be necessary." type="regular"><entity charOffset="76:83" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.0" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="discontinuation of ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="99:107" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitant diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="3:26" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.2" text="symptomatic hypotension" type="Specific_Interaction"/><entity charOffset="39:53" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.4" text="dose reduction" type="Increase_Interaction"/><entity charOffset="57:72" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.6" text="discontinuation" type="Caution_Interaction"/><entity charOffset="3:26" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.8" text="symptomatic hypotension" type="SPAN"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.2"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.4"><relations><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.ddi.3"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.6"><relations><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.1" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.43.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.45" text="Another angiotensin converting enzyme inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression, rarely in uncomplicated patients but more frequently in patients with renal impairment especially if they also have a collagen vascular disease. " type="negative"><entity charOffset="8:47" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.45.e.0" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="Another angiotensin converting enzyme inhibitor," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="49:58" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.45.e.1" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="captopril," preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.45.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.45.e.1"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.50" text="Rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice or hepatitis and progresses to fulminant hepatic necrosis and (sometimes) death. " type="negative"><entity charOffset="8:22" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.50.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="101:110" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.50.e.1" text="hepatitis" type="Biomedical_Entity"><Normalization><mmtx cui="C0795623" phraseText="hepatitis" preferredWord="Hepatitis A Vaccine, Inactivated" semType="phsu, imft"/><RxNorm RxCui="989819"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.50.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.50.e.1"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="75:91" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="168:179" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60.e.2" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60.e.1"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.60.e.2"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.73" text="Aortic Stenosis/Hypertrophic Cardiomyopathy: As with all vasodilators, lisinopril should be given with caution to patients with obstruction in the outflow tract of the left ventricle." type="negative"><entity charOffset="57:69" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.73.e.0" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="As with all vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="71:81" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.73.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.73.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.73.e.1"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.74" text="Impaired Renal Function: As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="78:89" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.74.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="66:77" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.74.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.74.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.74.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75" text="In patients with severe congestive heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with angiotensin converting enzyme inhibitors, including ZESTRIL, may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death." type="negative"><entity charOffset="157:197" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="122:133" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="110:121" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="209:216" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.3" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL," preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.0"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.0"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.3"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.1"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.3"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.75.e.3"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77" text="Experience with another angiotensin-converting enzyme inhibitor suggests that these increases are usually reversible upon discontinuation of ZESTRIL and/or diuretic therapy. " type="negative"><entity charOffset="141:148" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.0" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="usually reversible upon discontinuation of ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="156:164" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="24:63" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.2" text="angiotensin-converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="Experience with another angiotensin-converting enzyme inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.1"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.0"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.77.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79" lineNumber="67" text="Some patients with hypertension or heart failure with no apparent pre-existing renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when ZESTRIL has been given concomitantly with a diuretic. " type="regular"><entity charOffset="217:224" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.0" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="261:269" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitantly with a diuretic." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="19:31" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.2" text="hypertension" type="SPAN"><Normalization><mmtx cui="C0020538" phraseText="Some patients with hypertension" preferredWord="Hypertensive disease" semType="dsyn"/></Normalization></entity><entity charOffset="35:48" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.3" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="117:149" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.4" text="increases in blood urea nitrogen" type="Specific_Interaction"/><entity charOffset="117:129|154:170" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.6" text="increases in serum creatinine" type="Specific_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.4"><relations><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.6"><relations><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.3, Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.2" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.1" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.79.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81" lineNumber="67" text="Dosage reduction and/or discontinuation of the diuretic and/or ZESTRIL may be required." type="regular"><entity charOffset="0:16" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.0" text="Dosage reduction" type="Caution_Interaction"/><entity charOffset="24:39" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.2" text="discontinuation" type="Caution_Interaction"/><entity charOffset="47:55" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.4" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="discontinuation of the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="63:70" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.5" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.2"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.4" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.5" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.81.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90" lineNumber="73" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. " type="irregular"><entity charOffset="36:48" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.0" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="124:151" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.2" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="153:174" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.3" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="182:219" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.4" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes." preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.84" text="If renal dysfunction develops during treatment with ZESTRIL (serum creatinine concentration exceeding 3 mg/dL or a doubling from the pre-treatment value) then the physician should consider withdrawal of ZESTRIL."><entity charOffset="203:210" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.84.e.0" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="withdrawal of ZESTRIL." preferredWord="Zestril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.85" text="Evaluation of patients with hypertension, heart failure, or myocardial infarction should always include assessment of renal function (See DOSAGE AND ADMINISTRATION)."/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.86" text="Hyperkalemia: In clinical trials hyperkalemia (serum potassium greater than 5.7 mEq/L) occurred in approximately 2.2% of hypertensive patients and 4.8% of patients with heart failure. "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.87" text="In most cases these were isolated values which resolved despite continued therapy. "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.88" text="Hyperkalemia was a cause of discontinuation of therapy in approximately 0.1% of hypertensive patients; "/><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.89" text="0.6% of patients with heart failure and 0.1% of patients with myocardial infarction. "/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.3" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.4"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.4"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92" lineNumber="73" text="ZESTRIL should be used cautiously, if at all, with these agents and with frequent monitoring of serum potassium (See PRECAUTIONS, Drug Interactions)." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="51:63" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.3" text="these agents" type="Expression"/><antecedentEntity charOffset="124:151" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.2" text="potassium-sparing diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="51:63" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.3" text="these agents" type="Expression"/><antecedentEntity charOffset="153:174" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.3" text="potassium supplements" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="51:63" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.3" text="these agents" type="Expression"/><antecedentEntity charOffset="182:219" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.90.e.4" text="potassium-containing salt substitutes" type="Substance"/></anaphoraRelation><entity charOffset="0:7" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.0" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="23:33" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.1" text="cautiously" type="Caution_Interaction"/><entity charOffset="82:92" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.7" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.92.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95" lineNumber="77" text="Surgery/Anesthesia: In patients undergoing major surgery or during anesthesia with agents that produce hypotension, ZESTRIL may block angiotensin II formation secondary to compensatory renin release. " type="regular"><entity charOffset="67:77|83:114" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.0" text="anesthesia agents that produce hypotension" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="or during anesthesia" preferredWord="Anesthetics" semType="phsu"/><mmtx cui="C1254351" phraseText="with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="1021939"/></Normalization></entity><entity charOffset="116:123" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.1" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="128:198" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.2" text="block angiotensin II formation secondary to compensatory renin release" type="Specific_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.2"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.1" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.95.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98" lineNumber="81" text="Hypotension - Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ZESTRIL. " type="regular"><entity charOffset="56:65" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Patients on diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="178:205" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.1" text="reduction of blood pressure" type="Specific_Interaction"/><entity charOffset="239:246" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.3" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="with ZESTRIL." preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.98.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99" lineNumber="81" text="The possibility of hypotensive effects with ZESTRIL can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with ZESTRIL. " type="regular"><entity charOffset="19:38" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.0" text="hypotensive effects" type="Specific_Interaction"/><entity charOffset="44:51" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.2" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="with ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="97:105" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.99.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100" lineNumber="81" text="If it is necessary to continue the diuretic, initiate therapy with ZESTRIL at a dose of 5 mg daily, and provide close medical supervision after the initial dose until blood pressure has stabilized (See WARNINGS, and DOSAGE AND ADMINISTRATION). " type="regular"><entity charOffset="126:137" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.0" text="supervision" type="Caution_Interaction"/><entity charOffset="35:43" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.2" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="the diuretic," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="67:74" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.3" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="therapy with ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.100.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101" lineNumber="81" text="When a diuretic is added to the therapy of a patient receiving ZESTRIL, an additional antihypertensive effect is usually observed. " type="regular"><entity charOffset="7:15" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="63:70" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.1" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="added to the therapy of a patient receiving ZESTRIL," preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="75:109" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.2" text="additional antihypertensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.2"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.1" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.101.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102" lineNumber="81" text="Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic (See DOSAGE AND ADMINISTRATION)." type="regular"><entity charOffset="76:80|102:116" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.0" text="dose can be reduced" type="Increase_Interaction"/><entity charOffset="88:101" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.2" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="the dose of the ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="141:149" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.102.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103" lineNumber="83" text="Antidiabetics: Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicines (insulins, oral hypoglycemic agents) may cause an increased blood-glucose-lowering effect with risk of hypoglycemia. " type="regular"><entity charOffset="181:220" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.0" text="increased blood-glucose-lowering effect" type="Specific_Interaction"/><entity charOffset="234:246" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.2" text="hypoglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020615" phraseText="an increased blood-glucose-lowering effect with risk of hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/><mmtx cui="C0020615" phraseText="an increased blood-glucose-lowering effect with risk of hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/></Normalization></entity><entity charOffset="89:103" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="that concomitant administration of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="132:140" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.5" text="insulins" type="Drug_Class"><Normalization><mmtx cui="C0021641" phraseText="(insulins," preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C3537244" phraseText="(insulins," preferredWord="Insulins" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="142:166" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.6" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="108:130" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.7" text="antidiabetic medicines" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="antidiabetic medicines" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C0013227" phraseText="antidiabetic medicines" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.5" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.7"/><classClassMembership drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.6"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.2"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.4" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.7" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.103.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105" lineNumber="83" text="In diabetic patients treated with oral antidiabetic agents or insulin, glycemic control should be closely monitored for hypoglycemia, especially during the first month of treatment with an ACE inhibitor." type="regular"><entity charOffset="3:20" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.0" text="diabetic patients" type="SPAN"/><entity charOffset="34:58" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.1" text="oral antidiabetic agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="treated with oral antidiabetic agents" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.2" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin," preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin," preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin," preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="120:132" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.3" text="hypoglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020615" phraseText="monitored for hypoglycemia," preferredWord="Hypoglycemia" semType="dsyn"/></Normalization></entity><entity charOffset="189:202" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.5" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with an ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.3"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.0" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.5" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.3" type="Specific_Interaction"/><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.0" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.5" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.105.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106" lineNumber="85" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including lisinopril, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="127:134" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.0" text="elderly" type="SPAN"/><entity charOffset="136:151" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="199:225" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="248:254" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="266:292" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="299:313" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.6" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="325:335" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.7" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="351:382" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="403:422" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.4"/><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.7" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.6"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.9"><relations><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.11"><relations><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.0, Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.1, Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.2" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.3" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.6" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.106.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108" lineNumber="85" text="Monitor renal function periodically in patients receiving lisinopril and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:68" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.2" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="73:78" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.108.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109" lineNumber="87" text="The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs." type="regular"><entity charOffset="4:27|76:86" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.0" text="antihypertensive effect attenuated" type="Specific_Interaction"/><entity charOffset="31:45" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="The antihypertensive effect of ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="57:67" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.3" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="90:96" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.5" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.3" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.2"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.5" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="5:13" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110.e.0" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111" lineNumber="91" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109" text="The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs."><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.3"/></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109" text="The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs."><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.3"/></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.ddi.3"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109" text="The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs."><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.3"/></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.ddi.4"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109" text="The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs."><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.109.e.3"/></ellipsisSentence><middleSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.110" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.111.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112" lineNumber="91" text="Closely monitor blood pressure, renal function and electrolytes in patients on ZESTRIL and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:86" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.2" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="on ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="97:123" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.112.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113" lineNumber="93" text="Do not co-administer aliskiren with ZESTRIL in patients with diabetes. " type="regular"><entity charOffset="0:20" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ZESTRIL" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.3" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="aliskiren with ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="61:69" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.4" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.113.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114" lineNumber="93" text="Avoid use of aliskiren with ZESTRIL in patients with renal impairment (GFR &lt; 60 ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:35" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.3" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="with ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="53:69" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.4" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.114.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.115" text="Other Agents: ZESTRIL has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions. " type="negative"><entity charOffset="71:78" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.115.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin without evidence of clinically significant adverse interactions." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="14:21" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.115.e.1" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.115.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.115.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117" text="No clinically important pharmacokinetic interactions occurred when ZESTRIL was used concomitantly with propranolol or hydrochlorothiazide. " type="negative"><entity charOffset="118:137" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="103:114" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="concomitantly with propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="67:74" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.2" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.0"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.0"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.117.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119" lineNumber="97" text="Agents Increasing Serum Potassium: ZESTRIL attenuates potassium loss caused by thiazide-type diuretics. " type="regular"><entity charOffset="35:42" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.0" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="79:102" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.1" text="thiazide-type diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="caused by thiazide-type diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="43:68" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.2" text="attenuates potassium loss" type="Specific_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.1" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.119.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="8" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" lineNumber="97" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. " type="regular"><entity charOffset="7:14" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.0" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="Use of ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="20:47" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="with potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="55:69" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.2" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="71:81" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.3" text="eplerenone" type="Drug"><Normalization><mmtx cui="C0961485" phraseText="eplerenone," preferredWord="eplerenone" semType="strd, phsu"/><RxNorm RxCui="298869"/></Normalization></entity><entity charOffset="83:94" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.4" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="98:107" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.5" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="110:131" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.10" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="136:173" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.11" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="198:226" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.12" text="increases in serum potassium" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.2" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1"/><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.3" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1"/><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.4" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1"/><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.5" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.11" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.12" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.10" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.12" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.12" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.10" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.11"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.11"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.10"/></sentence><sentence biomedicalEntities="0" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.121" lineNumber="97" text="Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium. " type="irregular"><entity charOffset="121:128" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.121.e.0" text="caution" type="Caution_Interaction"/><entity charOffset="147:157" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.121.e.2" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.121.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.121.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.10"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.121.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.121.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.10"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120" text="Use of ZESTRIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.120.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122" lineNumber="97" text="Potassium-sparing agents should generally not be used in patients with heart failure who are receiving ZESTRIL." type="regular"><entity charOffset="0:24" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.0" text="Potassium-sparing agents" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="Potassium-sparing agents" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C1254351" phraseText="Potassium-sparing agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="42:53" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.1" text="not be used" type="Caution_Interaction"/><entity charOffset="71:84" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.3" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="with heart failure" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="with heart failure" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="103:110" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.4" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="receiving ZESTRIL." preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.1"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.3" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.4" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.122.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123" lineNumber="99" text="Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors. " type="regular"><entity charOffset="9:16" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.0" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="17:25" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="93:132" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.3" text="drugs which cause elimination of sodium" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="lithium concomitantly with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597484" phraseText="elimination of sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="144:158" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><classClassMembership drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.4"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.1"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.123.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124" lineNumber="99" text="Lithium toxicity was usually reversible upon discontinuation of lithium and the ACE inhibitor. " type="regular"><entity charOffset="8:16" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.0" text="toxicity" type="Increase_Interaction"/><entity charOffset="80:93" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.2" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.3" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.3" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.2" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.124.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125" lineNumber="99" text="It is recommended that serum lithium levels be monitored frequently if ZESTRIL is administered concomitantly with lithium." type="regular"><entity charOffset="47:56" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.0" text="monitored" type="Caution_Interaction"/><entity charOffset="71:78" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.2" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="114:121" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="concomitantly with lithium." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.125.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126" lineNumber="101" text="Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including ZESTRIL." type="regular"><entity charOffset="6:25" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.0" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="44:59" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.2" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="61:67" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.4" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.6" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><entity charOffset="82:93" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.8" text="hypotension" type="Specific_Interaction"/><entity charOffset="166:187" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="205:218" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="237:244" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.12" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="ZESTRIL." preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="149:164" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.14" text="injectable gold" type="Drug"><Normalization><mmtx cui="C0018026" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.12" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11"/><drugClassMembership drug="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10" drugClass="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.14"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.ddi.2"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.2"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.ddi.3"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.4"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.ddi.4"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.6"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.ddi.5"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.8"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.10" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.11" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.126.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.136" text="If blood pressure is not controlled with ZESTRIL alone, a low dose of a diuretic may be added. " type="negative"><entity charOffset="72:80" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.136.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a low dose of a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="41:48" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.136.e.1" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="controlled with ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.136.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.136.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.138" text="After the addition of a diuretic, it may be possible to reduce the dose of ZESTRIL." type="negative"><entity charOffset="75:82" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.138.e.0" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="the dose of ZESTRIL." preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="24:32" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.138.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="of a diuretic," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.138.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.138.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139" lineNumber="109" text="Diuretic Treated Patients: In hypertensive patients who are currently being treated with a diuretic, symptomatic hypotension may occur occasionally following the initial dose of ZESTRIL. " type="regular"><entity charOffset="101:124" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.0" text="symptomatic hypotension" type="Specific_Interaction"/><entity charOffset="178:185" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.2" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="the initial dose of ZESTRIL." preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="91:99" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="treated with a diuretic, symptomatic hypotension" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="30:51" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.4" text="hypertensive patients" type="SPAN"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.0"><relations><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.4" ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.3" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.2" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.139.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.140" text="The diuretic should be discontinued, if possible, for two to three days before beginning therapy with ZESTRIL to reduce the likelihood of hypotension (See WARNINGS). " type="negative"><entity charOffset="102:109" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.140.e.0" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="with ZESTRIL to" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="4:12" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.140.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="The diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.140.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.140.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.142" text="If the patient's blood pressure is not controlled with ZESTRIL alone, diuretic therapy may be resumed as described above." type="negative"><entity charOffset="70:78" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.142.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="controlled with ZESTRIL alone, diuretic therapy" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="55:62" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.142.e.1" text="zestril" type="Biomedical_Entity"><Normalization><mmtx cui="C0678140" phraseText="controlled with ZESTRIL alone, diuretic therapy" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.142.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.142.e.0"/></sentence><sentence id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.143" text="If the diuretic cannot be discontinued, an initial dose of 5 mg should be used under medical supervision for at least two hours and until blood pressure has stabilized for at least an additional hour (See WARNINGS and PRECAUTIONS, Drug Interactions)." type="negative"><entity charOffset="40:60" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.143.e.0" text="an 5" type="Biomedical_Entity"><Normalization><mmtx cui="C0526789" phraseText="an initial dose of 5 mg" preferredWord="AN(5)" semType="phsu, orch"/><RxNorm RxCui="707263"/></Normalization></entity><entity charOffset="7:15" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.143.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.143.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.143.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144" lineNumber="113" text="Concomitant administration of ZESTRIL with potassium supplements, potassium salt substitutes, or potassium-sparing diuretics may lead to increases of serum potassium (See PRECAUTIONS)." type="regular"><entity charOffset="30:37" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.0" text="ZESTRIL" type="Drug"><Normalization><mmtx cui="C0678140" phraseText="Concomitant administration of ZESTRIL" preferredWord="Zestril" semType="phsu, aapp"/><RxNorm RxCui="196472"/></Normalization></entity><entity charOffset="43:64" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.1" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="with potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="66:92" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.2" text="potassium salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium salt substitutes," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium salt substitutes," preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="97:124" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.3" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="137:165" id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.4" text="increases of serum potassium" type="Specific_Interaction"/><drugInteraction id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.ddi.1"><interaction trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.3" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.2" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.0" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.1" trigger="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.4" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.2" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.3"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.3"/><pair ddi="false" e1="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.1" e2="Dailymed.46f17ba7-a78c-4a9e-7597-27654f097bd3.s.144.e.2"/></sentence><positiveExamples number="40"/><negativeExamples number="50"/></document>